NCT00337038View on ClinicalTrials.gov

Endothelial Function as a Marker for Blood Pressure Control Among Hypertensive Diabetic Patients

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
HypertensionDiabetes Mellitus Type 2
Interventions
DRUG

N-acetylcystein(drug)

p.O t.Siran 200mg x1 during one weak

All Listed Sponsors
lead

Soroka University Medical Center

OTHER

NCT00337038 - Endothelial Function as a Marker for Blood Pressure Control Among Hypertensive Diabetic Patients | Biotech Hunter | Biotech Hunter